| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |